tbkg.osimertinib_case_study

is a Product.

Clinical validation dataset with calculated ADRs for osimertinib ranked by importance, biomarker pathways explaining drug-ADR relationships, and clinical data from 8 lung adenocarcinoma patients. Model achieved Kappa=0.68 concordance with official manual and 0.81 three-fold cross-validation accuracy.

Format

mixed

License

Warning: No license entered

Latest Version

Unknown

Sources

Original Source(s)

Is this information incorrect or incomplete? Request an update.